Portfolio (Quarterly)
Guide ↗
JOHNSON & JOHNSON
· CIK 0000200406| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PTGX | Protagonist Therapeutics Inc. | Healthcare | 2,449,183.0 | $213.9M | 38.54% | NEW | — | $87.34 | +29.2% |
| 2 | NBTX | Nanobiotix S.A. | Healthcare | 5,623,816.0 | $130.0M | 23.43% | NEW | — | $23.12 | +56.9% |
| 3 | RAPP | Rapport Therapeutics, Inc. | Healthcare | 1,784,517.0 | $54.1M | 9.76% | NEW | — | $30.34 | +23.1% |
| 4 | MGTX | MeiraGTx Holdings plc | Healthcare | 6,641,064.0 | $52.8M | 9.51% | NEW | — | $7.95 | +42.4% |
| 5 | CVRX | CVRx, Inc. | Healthcare | 4,024,861.0 | $28.6M | 5.15% | NEW | — | $7.10 | -30.3% |
| 6 | CTNM | Contineum Therapeutics Inc. | Healthcare | 1,979,173.0 | $22.6M | 4.08% | NEW | — | $11.43 | +4.5% |
| 7 | LEGN | Legend Biotech Corporation | Healthcare | 814,586.0 | $17.7M | 3.19% | NEW | — | $21.74 | +28.5% |
| 8 | XNCR | Xencor, Inc. | Healthcare | 748,062.0 | $11.5M | 2.06% | NEW | — | $15.31 | -17.4% |
| 9 | PRCT | Procept BioRobotics Corporation | Healthcare | 357,939.0 | $11.3M | 2.03% | NEW | — | $31.46 | -31.0% |
| 10 | FATE | Fate Therapeutics, Inc. | Healthcare | 3,379,064.0 | $3.3M | 0.60% | NEW | — | $0.98 | +112.7% |
| 11 | NMRA | Neumora Therapeutics, Inc. | Healthcare | 1,849,445.0 | $3.3M | 0.60% | NEW | — | $1.79 | -15.6% |
| 12 | — | Rallybio Corporation | — | 3,636,363.0 | $2.5M | 0.45% | NEW | — | $0.69 | — |
| 13 | LYEL | Lyell Immunopharma, Inc. | Healthcare | 54,887.0 | $1.7M | 0.30% | NEW | — | $30.78 | -58.6% |
| 14 | VOR | Vor Biopharma, Inc. | Healthcare | 53,732.0 | $703K | 0.13% | NEW | — | $13.08 | +10.8% |
| 15 | NNOX | Nano-X Imaging Ltd. | Healthcare | 158,852.0 | $445K | 0.08% | NEW | — | $2.80 | -40.4% |
| 16 | LAB | Standard BioTools, Inc. | Healthcare | 311,967.0 | $399K | 0.07% | NEW | — | $1.28 | -35.2% |
| 17 | — | Adicet Bio, Inc. | — | 22,779.0 | $192K | 0.04% | NEW | — | $8.42 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%